Novo Nordisk has reported 22% weight loss in people who received weekly amycretin injections for 36 weeks, triggering an 11% jump in the Danish drugmaker’s share price in premarket trading.

“We are very encouraged by the subcutaneous phase 1b/2a results for amycretin in people living with overweight or obesity,” said Martin Lange, executive vice president for Development at Novo ...

An elderly man reported missing on Tuesday evening has been found dead in Nuevo Laredo, Mexico, authorities said. On Wednesday morning, Laredo police confirmed that Danson Len Trotti, 77 ...

“We are very encouraged by the subcutaneous phase 1b/2a results for amycretin in people living with overweight or obesity,” said Martin Lange, executive vice president for Development at Novo Nordisk.

Magazine and Reach PLC magazines. REUTERS/Luis Manuel Lopez A collision between a bus and a truck has killed 41 people in Mexico, according to reports. The incident occurred in the early hours of ...

Last week, Webb County Sheriff Martin Cuellar issued a statement that U.S. residents should take precautions when traveling into Nuevo Laredo, Mexico, which is across the Rio Grande from Laredo.

Novo Nordisk said on Wednesday that its emissions rose by nearly a quarter in 2024 and will continue to increase up to 2030 as production increases to meet demand for its obesity blockbuster Wegovy.

the Novo Nordisk Foundation reached a new milestone, awarding close to DKK 10.1 billion (€1.35 billion) to support nearly 1,800 new projects aimed at improving people's health and the ...

Novo Nordisk announced phase 1b/2a clinical trial results for amycretin this morning. Patients taking the GLP-1 drug lost an average of 9.7% of their weight in 36 weeks. This is the best news Novo ...

Novo Nordisk A/S rose the most since August 2023 after its experimental shot delivered as much as 22% weight loss in an early-stage trial, boosting investors’ hopes for the drugmaker’s pipeline.